{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:51:04Z","timestamp":1782449464851,"version":"3.54.5"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epithelioid sarcoma is an exceedingly rare malignant soft tissue neoplasm with unclear histogenesis and distinctive epithelioid morphology. Primary epithelioid sarcoma of orbit represents an extremely rare clinical entity, with only isolated case reports documented globally. Notably, no formal, peer-reviewed case report of primary epithelioid sarcoma of orbit has been published in Asia to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 25-year-old male patient presented with slowly progressive, painless proptosis of the left eye. Orbital MRI revealed an irregular mass in the superomedial extraconal space of the left orbit, with an initial radiological impression of vascular tumor or inflammatory lesion. Histologically, the tumor displayed characteristic multinodular growth, composed of a mixture of epithelioid and spindle cells with necrotizing granuloma-like changes. Skeletal muscle invasion and vascular tumor emboli were observed. Immunohistochemically, tumor cells co-expressed epithelial markers (broad-spectrum CK, EMA), mesenchymal marker (Vimentin) and CD34, with loss of nuclear INI1 (SMARCB1) expression. Whole-body PET-CT performed postoperatively excluded distant metastasis, and a diagnosis of classic primary epithelioid sarcoma of the left orbit was confirmed. The patient underwent extended tumor resection combined with local intensity-modulated radiotherapy. No local recurrence or distant metastasis was detected at 7 months postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Primary epithelioid sarcoma of the orbit is diagnostically challenging, and pathological examination remains the gold standard for diagnosis. The combination of characteristic histological features and a distinct immunophenotype (loss of INI1) is critical for definitive diagnosis and differential diagnosis. We report the first case of primary epithelioid sarcoma of orbit in Asia, which enriches the clinicopathological data of this rare tumor in the Asian population and provides a key reference for its clinical management and pathological diagnosis. However, as a single-case study, larger series are needed to confirm generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1836728","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:37:07Z","timestamp":1782448627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Primary epithelioid sarcoma of orbit: first case in Asia and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Guang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pathology, Renmin Hospital of Wuhan University","place":["Wuhan, China"]},{"name":"Department of Pathology, People\u2019s Hospital of Luotian County","place":["Huanggang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197011)26:5<1029::AID-CNCR2820260510>3.0.CO;2-R","article-title":"Epithelioid sarcoma. A sarcoma simulating a granuloma or a carcinoma","volume":"26","author":"Enzinger","year":"1970","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000047651","article-title":"Prognostic determinants and survival outcomes in epithelioid sarcoma: A contemporary population-based analysis of 1123 patients","volume":"105","author":"Obeidat","year":"2026","journal-title":"Medicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000102","article-title":"Epithelioid sarcoma: Diagnostic features and genetics","volume":"23","author":"Thway","year":"2016","journal-title":"Adv Anatomic Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199702000-00002","article-title":"Proximal-type\" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series","volume":"21","author":"Guillou","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"B5","volume-title":"Enzinger and Weiss's Soft Tissue Tumors","author":"Folpe","year":"2025"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(94)31115-8","article-title":"Epithelioid sarcoma of the orbit","volume":"101","author":"White","year":"1994","journal-title":"Ophthalmology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.75589","article-title":"Epithelioid sarcoma of the orbit","volume":"31","author":"Alkatan","year":"2011","journal-title":"Ann Saudi Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-013-2780-6","article-title":"Epithelioid sarcoma of the orbit","volume":"62","author":"Thranitz","year":"2014","journal-title":"HNO"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000227","article-title":"Orbital epithelioid sarcoma: A case report","volume":"32","author":"Jurdy","year":"2016","journal-title":"Ophthalmic Plast Reconstructive Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3989716","article-title":"Primary epithelioid sarcoma of orbit: A case report and review of the literature","volume":"2018","author":"Kaya","year":"2018","journal-title":"Case Rep Oncological Med"},{"key":"B11","volume-title":"NCCN Clinical Practice Guidelines in Oncology: Soft Tissue Sarcoma","year":"2026"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0b013e3181882c54","article-title":"Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma","volume":"33","author":"Hornick","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B14","volume-title":"WHO Classification of Tumours of Soft Tissue and Bone","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(99)90247-2","article-title":"Epithelioid sarcoma: An immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis","volume":"30","author":"Miettinen","year":"1999","journal-title":"Hum Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01148-x","article-title":"The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms","volume":"35","author":"Dermawan","year":"2022","journal-title":"Mod Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.175","article-title":"Epithelioid sarcoma is associated with a high rate of SMARCB1 (INI1) deletions and mutations","volume":"44","author":"Sullivan","year":"2013","journal-title":"Hum Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0b013e318161781a","article-title":"SMARCB1\/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations","volume":"40","author":"Kohashi","year":"2009","journal-title":"Hum Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100647","article-title":"Proximal and classic epithelioid sarcomas are distinct molecular entities defined by MYC\/GATA3 and SOX17\/endothelial markers, respectively","volume":"38","author":"Sigalotti","year":"2025","journal-title":"Mod Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5114\/pjp.2012.31502","article-title":"Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma","volume":"63","author":"Mularz","year":"2012","journal-title":"Pol J Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31828de23a","article-title":"ERG expression in epithelioid sarcoma: a diagnostic pitfall","volume":"37","author":"Miettinen","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.08.014","article-title":"A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics","volume":"44","author":"Arnold","year":"2013","journal-title":"Hum Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.175","article-title":"Selected topics in the pathology of epithelioid soft tissue tumors","volume":"27","author":"Goldblum","year":"2014","journal-title":"Mod Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.08.007","article-title":"Infrequent SMARCB1\/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from Malignant rhabdoid tumor","volume":"40","author":"Kohashi","year":"2009","journal-title":"Hum Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(20)30451-4","article-title":"Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study","volume":"21","author":"Gounder","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1836728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:37:33Z","timestamp":1782448653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1836728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":25,"alternative-id":["10.3389\/fonc.2026.1836728"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1836728","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1836728"}}